● The company has strong fundamentals. More than 70% of listed companies have a lower mix of growth, profitability, debt and visibility criteria.
● The company has solid fundamentals for a short-term investment strategy.
Strengths
● Growth is a substantial asset for the company, as anticipated by dedicated analysts. Within the next three years, growth is estimated to reach 92% by 2023.
●
● The company is one of the most undervalued, with an "enterprise value to sales" ratio at 0.78 for the 2021 fiscal year.
● Over the last twelve months, the sales forecast has been frequently revised upwards.
● Over the last 4 months, analysts have significantly revised upwards the company's estimated sales.
● For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
● For several months, analysts have been revising their EPS estimates roughly upwards.
●
●
●
Weaknesses
●
● The company does not generate enough profits, which is an alarming weak point.
● The firm trades with high earnings multiples: 43.1 times its 2021 earnings per share.
●
● Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
●